PUBLISHER: The Business Research Company | PRODUCT CODE: 1889506
PUBLISHER: The Business Research Company | PRODUCT CODE: 1889506
Methylsulfonylmethane (MSM) supplements are dietary products containing a naturally occurring sulfur compound that supports joint health, reduces inflammation, and promotes healthy skin, hair, and nails. They are often used to improve mobility, reduce pain, and support overall connective tissue health.
The key product forms in methylsulfonylmethane (MSM) supplements are powders, capsules, tablets, liquids, and softgels. Powders are a versatile option that can be easily mixed with water, juice, or other beverages. These supplements are available in various formulations, including organic MSM supplements, synthetic MSM supplements, non-GMO MSM supplements, vegan MSM supplements, and allergen-free MSM supplements. They are distributed through channels such as online retailers, supermarkets or hypermarkets, health and wellness stores, pharmacies and drugstores, and direct sales. They are used for applications such as joint health, skin care, allergies and immune support, sports nutrition, and others, targeting users such as athletes and bodybuilders, health-conscious consumers, individuals with joint disorders, general fitness enthusiasts, and the aging population.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The methylsulfonylmethane (MSM) supplements market research report is one of a series of new reports from The Business Research Company that provides methylsulfonylmethane (MSM) supplements market statistics, including the methylsulfonylmethane (MSM) supplements industry global market size, regional shares, competitors with the methylsulfonylmethane (MSM) supplements market share, detailed methylsulfonylmethane (MSM) supplements market segments, market trends, and opportunities, and any further data you may need to thrive in the methylsulfonylmethane (MSM) supplements industry. This methylsulfonylmethane (MSM) supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The methylsulfonylmethane (MSM) supplements market size has grown strongly in recent years. It will grow from $1.23 billion in 2024 to $1.34 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be linked to increasing prevalence of joint disorders, growing consumer health awareness, rising e-commerce access, expansion of the aging population, and increasing demand from the sports nutrition sector.
The methylsulfonylmethane (MSM) supplements market size is expected to see rapid growth in the next few years. It will grow to $1.90 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be driven by increasing awareness about organic supplements, growing preference for personalized nutrition, rising adoption of online retail channels, expansion of the fitness and wellness market, and increasing demand for combination supplements. Major trends in the forecast period include advancements in MSM extraction, innovations in plant-based MSM supplements, developments in convenient dosage forms, research and developments in joint and skin health, and technology-driven personalized nutrition solutions.
The rising prevalence of joint disorders is expected to drive growth in the methylsulfonylmethane (MSM) supplements market in the coming years. Joint disorders, such as osteoarthritis and rheumatoid arthritis, involve damage or inflammation of the joints, causing discomfort and limited movement. The incidence of these conditions is increasing due to factors like sedentary lifestyles and obesity. MSM supplements are commonly used as a complementary treatment to support joint health by reducing inflammation, relieving pain, and potentially aiding in cartilage repair, though usage varies by individual. For example, in March 2025, the Health Equity Evidence Centre, a UK-based organization, estimated that 17.1 million people in England were living with musculoskeletal (MSK) conditions, including arthritis and ongoing back or joint issues. As a result, the rising prevalence of joint disorders is fueling the growth of the MSM supplements market.
The growth of the aging population is expected to contribute to the expansion of the MSM supplements market. An aging population refers to a growing share of older individuals within a society, driven by increased life expectancy and declining birth rates. This demographic shift is supported by advancements in healthcare that have extended life expectancy. Older adults often use MSM supplements to support joint health, reduce inflammation, and maintain mobility, although individual usage varies. For instance, in January 2024, the Population Reference Bureau, a U.S.-based nonprofit, reported that the number of Americans aged 65 and older is projected to rise from 58 million in 2022 to 82 million by 2050, a 47% increase. During the same period, the proportion of this age group in the total U.S. population is expected to grow from 17% to 23%. Consequently, the increase in the aging population is driving the growth of the MSM supplements market.
Leading companies in the MSM supplements market are focusing on developing clinically proven formulations to enhance joint health, mobility, and overall wellness with safe and effective nutritional solutions. For instance, in June 2025, Balchem Corporation, a U.S.-based health product manufacturer, received Food with Functional Claims (FFC) approval from Japan's Consumer Affairs Agency for OptiMSM, making it the first MSM product to receive this recognition. The approval was supported by a clinical study demonstrating that a 2,000 mg daily dose improved joint comfort and reduced knee pain, confirming OptiMSM's safety and effectiveness. Already GRAS-certified in the U.S., OptiMSM is known for supporting joint and connective tissue health by providing essential sulfur for cartilage. The FFC approval allows manufacturers in Japan to feature joint health claims on their product packaging, further solidifying OptiMSM's leadership in the joint health and mobility segment of Japan's expanding functional food market.
Major companies operating in the methylsulfonylmethane (msm) supplements market are The Nature's Bounty Co., NOW Health Group Inc. (NOW Foods), Thorne HealthTech Inc., Jarrow Formulas Inc., Life Extension Foundation Buyers Club Inc., Swanson Health Products Inc., KAL Vitamins (a brand of Nutraceutical Corporation), Pure Encapsulations LLC, Solgar Inc., NutraScience Labs Inc., NutraBio Labs Inc., Bulksupplements.com LLC, Pure Organic Ingredients LLC, Puritan's Pride Inc., PharmaFreak Holdings Inc., Vita-Flex Nutrition Inc., Source Naturals Inc., Kala Health Inc., Zenwise LLC (Zenwise Health), Bergstrom Nutrition Inc.
North America was the largest region in the methylsulfonylmethane (MSM) supplements market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in methylsulfonylmethane (MSM) supplements report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the methylsulfonylmethane (MSM) supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The methylsulfonylmethane (MSM) supplements market consists of sales of gummies, chewable supplements, effervescent granules, topical creams, gels, lotions, and functional beverages. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Methylsulfonylmethane (MSM) Supplements Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on methylsulfonylmethane (msm) supplements market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for methylsulfonylmethane (msm) supplements ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The methylsulfonylmethane (msm) supplements market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.